checkAd
    Startseite > Aktien > Ipsen > Nachrichten
    Ipsen Aktie
    121,60
     
    EUR
    -0,90 %
    -1,10 EUR
    Letzter Kurs 15:28:55 Tradegate
    121,80
     
    EUR
    41 STK
    Geldkurs 15:44:25
    122,00
     
    EUR
    40 STK
    Briefkurs 15:44:25
    ISIN: FR0010259150 · WKN: A0ESMG · SYM: I7G · Frankreich ·

    Neueste Nachrichten

    Ipsen and Marengo Therapeutics announce second strategic partnership to advance precision T cell engagers from Marengo’s Tri-STAR platform
    07.06.24 · globenewswire · Ipsen
    Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
    06.06.24 · globenewswire · Ipsen
    Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer   
    06.06.24 · globenewswire · Ipsen
    Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with primary biliary cholangitis    
    05.06.24 · globenewswire · Ipsen
    Ipsen initiates a share buy-back program to cover its free employee share-allocation plan
    03.06.24 · globenewswire · Ipsen
    Ipsen announces the launch of an employee shareholding plan
    30.05.24 · globenewswire · Ipsen
    Annual General Meeting of Ipsen S.A. held on 28 May 2024
    28.05.24 · globenewswire · Ipsen
    Description of the regulatory framework of the share repurchase program proposed by the Board of Directors to be approved at Ipsen S.A.’s Annual General Meeting on 28 May 2024
    28.05.24 · globenewswire · Ipsen
    Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting
    07.05.24 · globenewswire · Ipsen
    Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
    06.05.24 · globenewswire · Ipsen
    Ipsen appoints Keira Driansky as EVP, President of North America
    02.05.24 · globenewswire · Ipsen
    Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
    24.04.24 · globenewswire · Ipsen